Parallax Volatility Advisers, L.P. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,038,613
+31.4%
8,568
+24.2%
0.00%
+200.0%
Q2 2023$790,188
-94.9%
6,900
-93.8%
0.00%
-96.8%
Q1 2023$15,354,262
-24.2%
111,400
-28.8%
0.03%0.0%
Q4 2022$20,266,312
+231.0%
156,400
+182.3%
0.03%
+244.4%
Q3 2022$6,123,000
+227.8%
55,400
+122.2%
0.01%
+800.0%
Q2 2022$1,868,000
+0.8%
24,931
+5.0%
0.00%0.0%
Q1 2022$1,854,000
-79.8%
23,739
-76.7%
0.00%
-87.5%
Q4 2021$9,193,000
+38.6%
102,100
+42.4%
0.01%
+100.0%
Q3 2021$6,631,000
-14.7%
71,702
-28.3%
0.00%
-33.3%
Q2 2021$7,773,000
+97.3%
100,000
+89.2%
0.01%
+50.0%
Q1 2021$3,939,000
-33.3%
52,861
+52.4%
0.00%0.0%
Q4 2020$5,909,000
-80.8%
34,685
-84.2%
0.00%
-82.6%
Q3 2020$30,762,000
+88.7%
219,311
+115.4%
0.02%
+21.1%
Q2 2020$16,304,000
+374.2%
101,800
+190.1%
0.02%
+280.0%
Q1 2020$3,438,000
-1.7%
35,097
+29.4%
0.01%
+25.0%
Q4 2019$3,499,000
+3.7%
27,115
-39.5%
0.00%
+33.3%
Q3 2019$3,374,000
+68.6%
44,787
+240.1%
0.00%
+50.0%
Q2 2019$2,001,000
+74.3%
13,168
+36.7%
0.00%
+100.0%
Q1 2019$1,148,000
-47.4%
9,635
-51.8%
0.00%
-66.7%
Q4 2018$2,183,000
-32.4%
20,0000.0%0.00%
-25.0%
Q3 2018$3,230,000
-58.8%
20,000
-66.3%
0.00%
-63.6%
Q2 2018$7,834,000
+428.6%
59,267
+196.3%
0.01%
+450.0%
Q1 2018$1,482,000
-21.5%
20,000
-41.0%
0.00%
-33.3%
Q4 2017$1,887,000
+670.2%
33,907
+529.8%
0.00%
Q3 2017$245,000
-91.8%
5,384
-93.9%
0.00%
-100.0%
Q2 2017$2,990,000
+931.0%
88,700
+803.9%
0.01%
+500.0%
Q1 2017$290,000
-97.4%
9,813
-97.5%
0.00%
-95.2%
Q4 2016$10,972,000
-50.7%
400,000
+10.3%
0.02%
-48.8%
Q3 2016$22,265,000
+1067.5%
362,549
+262.5%
0.04%
+925.0%
Q2 2016$1,907,000
+41.2%
100,000
+185.7%
0.00%
+33.3%
Q4 2015$1,351,000
+20.2%
35,0000.0%0.00%
+50.0%
Q3 2015$1,124,000
+5.5%
35,0000.0%0.00%0.0%
Q2 2015$1,065,00035,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,315,000$170,397,70013.20%
EcoR1 Capital, LLC 2,999,453$388,669,12011.83%
Evolutionary Tree Capital Management, LLC 63,756$8,261,5027.93%
Tri Locum Partners LP 119,695$15,510,0006.27%
Avoro Capital Advisors LLC 3,175,000$411,416,5006.15%
Camber Capital Management LP 1,250,000$161,9755.56%
Finepoint Capital LP 131,457$17,0345.51%
ACUTA CAPITAL PARTNERS, LLC 67,500$8,746,6505.38%
Logos Global Management LP 220,000$28,507,6003.34%
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP 33,454$3,401,6573.20%
View complete list of SAREPTA THERAPEUTICS INC shareholders